The Ayurvedic concept of grahani roga and the modern concept of increased intestinal permeability describe digestive dysfunction from different frameworks. In Charaka Samhita, grahani is discussed in Chikitsa Sthana, Chapter 15, as the seat of agni that holds undigested food and releases it after digestion. When agni becomes weak or disturbed, grahani releases food in an incompletely processed form associated with ama, irregular stool, weakness, abdominal discomfort, and impaired nourishment.

Modern gastroenterology describes the intestinal lining as a selective barrier. The small-intestinal epithelium absorbs nutrients while limiting the passage of larger molecules, microbial products, and inflammatory triggers. Tight junction proteins, including claudins, occludin, junctional adhesion molecules, and zonula occludens scaffold proteins, help regulate this paracellular barrier. When barrier selectivity is altered, permeability testing may help characterize one part of the clinical picture, but it does not by itself diagnose grahani roga.

This article reviews verified permeability-related tests, classical grahani assessment, and a practical way to compare both systems without treating them as identical diagnoses.

Modern Gut Permeability and Barrier Tests

Modern tests do not measure one single entity called “leaky gut.” They examine different layers of gut function: sugar-probe permeability, intestinal inflammation, epithelial cell injury, and microbial endotoxin exposure. Their results are most useful when interpreted together with symptoms, examination, diet, medication use, and standard gastroenterology evaluation.

The Lactulose-Mannitol Test in Detail

The lactulose-mannitol ratio is one of the best-established functional sugar-probe approaches for assessing intestinal permeability. The person ingests a solution containing lactulose and mannitol, then urine is collected for a defined period. Mannitol is smaller and is absorbed more readily, while lactulose is larger and is recovered in lower amounts when the barrier is intact. A higher lactulose-to-mannitol recovery ratio suggests increased paracellular passage or altered small-intestinal barrier function.

The main practical limitation is standardization. Collection duration, sugar dose, laboratory method, diet before testing, medication exposure, intestinal transit, and renal handling can change results. For this reason, the result should be interpreted using that laboratory’s reference range rather than a universal cut-off.

Zonulin and Its Assay Caveat

Zonulin is associated with reversible regulation of intestinal tight junctions and has become a popular marker in gut-barrier testing. Gliadin exposure and bacterial triggers have been described in relation to zonulin release and intestinal barrier regulation. In practice, however, zonulin testing requires caution because commonly used commercial assays may detect haptoglobin, complement C3, properdin, or zonulin-family peptides rather than true pre-haptoglobin 2.

A zonulin result is therefore best treated as an adjunctive signal rather than a standalone diagnosis. When symptoms are significant, it should be interpreted alongside medical history, stool pattern, inflammatory markers, celiac evaluation when indicated, medication exposure, and standard gastroenterology assessment.

Grahani Diagnosis: The Classical Approach

Grahani roga is a clinical Ayurvedic diagnosis centered on agni, ama, stool character, appetite, abdominal sensations, strength, and dosha predominance. Charaka Samhita describes weak agni as producing partial digestion and explains that a disturbed grahani releases incompletely digested material. This is a digestive-function model, not a molecular tight-junction model, but the two can be compared when the comparison remains clinically cautious.

The Four Types of Grahani Roga

Charaka Samhita classifies grahani roga into four types according to dosha predominance. The following descriptions keep the classical symptom pattern primary and use modern tests only as supportive tools for differential assessment.

• Vataja grahani: Marked by difficult digestion, abdominal distension during digestion, dryness of the mouth and throat, emaciation, weakness, cutting pain, altered taste, reduced mental strength, and stool that may be watery, dry, small, mixed with flatus, or mixed with undigested food. Modern work-up may focus on functional bowel patterns, malabsorption, celiac screening when appropriate, constipation-diarrhea cycling, and permeability testing only when barrier assessment is clinically relevant.
• Pittaja grahani: Marked by loose or watery stool with undigested food particles, yellowish or bluish-yellow coloration, foul or sour eructation, burning in the chest or throat region, anorexia, and thirst. Modern work-up may prioritize inflammatory or acid-peptic features, stool infection assessment when clinically indicated, fecal calprotectin, celiac testing, and other gastroenterology evaluation if diarrhea is persistent.
• Kaphaja grahani: Marked by slow or difficult digestion, nausea, vomiting, anorexia, coated mouth, sweet taste, cough, frequent spitting, heaviness in the chest or abdomen, foul sweet eructation, mucus-mixed stool, laziness, and weakness even without marked wasting. Modern work-up may consider mucus-associated bowel disorders, dietary intolerance, dysbiosis-related symptoms, and breath testing when small-intestinal bacterial overgrowth is suspected.
• Sannipataja grahani: Marked by combined features of vata, pitta, and kapha involvement. Because mixed and severe presentations can overlap with inflammatory, infectious, autoimmune, malabsorptive, endocrine, or structural disease, a complete medical evaluation is more important than relying on permeability markers alone.

Where the Two Systems Can Be Compared

The useful overlap between grahani and intestinal permeability is not a one-to-one diagnostic equivalence. Ayurveda asks whether digestive fire is steady, whether food is being properly processed, whether stool retains ama features, and which dosha pattern dominates. Modern testing asks whether the intestinal barrier, inflammatory state, epithelial integrity, or microbial translocation markers are altered. Used together, they can provide a wider clinical picture: classical assessment describes the digestive pattern, while laboratory testing helps identify inflammation, mucosal injury, malabsorption, infection, or barrier dysfunction.

This comparison is strongest when used as an integrative assessment map. A person can have grahani-like symptoms with normal permeability tests, and a person can have abnormal permeability markers due to an identifiable biomedical disorder. Persistent or severe symptoms therefore require medical evaluation rather than interpretation through either system alone.

Ayurvedic Measures Traditionally Used in Grahani

Classical Ayurvedic management of grahani roga is individualized according to agni, ama, dosha predominance, strength, stool pattern, and associated symptoms. The recurring principles are langhana when ama is prominent, pachana and deepana to improve digestive processing, grahi measures when loose stool requires stabilization, and dosha-specific cleansing only when the patient and disease stage are suitable.

• Takra: Charaka Samhita praises buttermilk in grahani dosha because it is described as deepana, grahi, and light to digest. It is not a generic recommendation for every patient; the form, preparation, spices, dose, and timing are selected by the practitioner according to dosha and digestive strength.
• Kutaja: The Ayurvedic Pharmacopoeia of India identifies Kutaja stem bark as the dried stem bark of Holarrhena antidysenterica. Its listed properties include tikta and kashaya rasa, laghu and ruksha guna, shita virya, katu vipaka, and actions including dipana, sangrahi, and kaphapittashamaka. API-listed therapeutic uses include atisara and pravahika, making it relevant to loose-stool patterns under qualified supervision.
• Diet after shodhana: In pitta-dominant grahani, Charaka Samhita describes physician-directed elimination when indicated, followed by food that is light, non-burning, bitter-associated, and supported by deepana and grahi measures. This is a supervised clinical sequence, not a home detox protocol.
• Deepana and pachana measures: Classical management repeatedly returns to correcting weak or disturbed agni. Spices, medicated ghee, powders, gruels, and fermented preparations appear in the chapter according to dosha, stool quality, and strength. These should be selected individually rather than copied from a generic list.
• Triphala and gut-supportive herbs: Triphala is widely discussed in Ayurveda and modern gut-microbiome literature, but it should not be treated as a specific substitute for grahani diagnosis. For a separate discussion, see How Triphala Reshapes Your Gut.

An Integrative Diagnostic Protocol

A practical integrative protocol starts with conventional safety screening and then adds Ayurvedic pattern assessment. This prevents a chronic digestive complaint from being mislabeled as grahani or “leaky gut” before serious causes are excluded.

1. Screen for red flags first: Unexplained weight loss, blood in stool, persistent night symptoms, anemia, fever, recurrent vomiting, severe abdominal pain, family history of colorectal cancer or inflammatory bowel disease, and new symptoms after midlife require medical evaluation.
2. Assess the classical pattern: Evaluate appetite, meal tolerance, stool form, stool frequency, undigested food, mucus, burning, thirst, distension, heaviness, strength, tongue findings, and dosha predominance. Identify whether the presentation is closer to vataja, pittaja, kaphaja, or sannipataja grahani.
3. Use modern tests for specific questions: Use fecal calprotectin to assess inflammatory activity, celiac serology when symptoms or risk factors fit, stool testing when infection is possible, breath testing when SIBO is suspected, and LMR when a permeability question will change management.
4. Interpret discordance carefully: A classical grahani pattern with normal inflammatory markers may still require diet, routine, and agni-focused care. Abnormal calprotectin, anemia, blood in stool, persistent diarrhea, or significant weight loss should shift priority toward gastroenterology evaluation.
5. Retest only when useful: Laboratory retesting should be reserved for markers that guide clinical decisions, such as calprotectin in inflammatory bowel disease monitoring or repeat testing after a defined intervention when a physician considers it meaningful.

Limitations and Safety

Grahani roga and increased intestinal permeability are not interchangeable diagnoses. Grahani is a classical Ayurvedic digestive disorder centered on agni, ama, dosha, and stool pattern. Intestinal permeability is a measurable barrier function that can be altered in specific biomedical conditions. “Leaky gut syndrome” is a popular term and is not a formal standalone medical diagnosis in mainstream clinical practice.

Permeability markers can also be misleading when used outside a full clinical context. Zonulin assay specificity, variable LMR protocols, medication effects, infection, alcohol intake, renal function, and inflammatory disorders can all affect interpretation. Fecal calprotectin and I-FABP add useful information in selected cases, but neither is a complete digestive diagnosis.

For those interested in how anti-inflammatory herbs are discussed in relation to gut and systemic inflammation, COX-2 Inhibition Explained provides a separate herb-focused discussion.

References

1. Charaka Samhita — Grahani Chikitsa
2. Ayurvedic Pharmacopoeia of India
3. Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases (2015), PubMed Central
4. Journals (journals.plos.org)
5. Measurement of intestinal permeability using lactulose and mannitol with conventional five hours and shortened two hours urine collection by two different methods: HPAE-PAD and LC-MSMS (2019), PubMed Central
6. Journals (journals.plos.org)
7. Frontiersin (frontiersin.org)
8. Faecal Calprotectin (2018), PubMed Central
9. Intestinal Fatty Acid Binding Protein, a Biomarker of Intestinal Barrier, is Associated with Severity of Psoriasis (2019), PubMed Central
10. Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14 (2013), PubMed Central
11. Intestinal Barrier Dysfunction, LPS Translocation, and Disease Development (2020), PubMed Central
12. My (my.clevelandclinic.org)
13. Health (health.harvard.edu)
14. Therapeutic Uses of Triphala in Ayurvedic Medicine (2017), PubMed Central
15. A clinical study on the role of ama in relation to Grahani Roga and its management by Kalingadi Ghanavati and Tryushnadi Ghrita (2010), PubMed
16. Evaluation of antidiarrheal activity of ethanolic extract of Holarrhena antidysenterica seeds in rats (2015), PubMed
17. Clinical evaluation of Bilvadileha in the management of irritable bowel syndrome (2013), PubMed

Rasayana and Modern Anti-Aging: Comparing Ayurvedic Rejuvenation With Geroscience

Rasayana is Ayurveda’s classical discipline of promotive and rejuvenative care. Modern geroscience, by contrast, studies the biological processes that contribute to aging and tests interventions against measurable cellular and clinical outcomes. A 2020 review in the Journal of Clinical Medicine, “Telomeres, DNA Damage and Ageing: Potential Leads from Ayurvedic Rasayana (Anti-Ageing) Drugs,” brought these fields into dialogue by examining telomere biology, DNA damage, oxidative stress and selected Rasayana substances. The paper is a translational review and does not report a clinical trial of human lifespan extension.

The two frameworks can be compared usefully when their terms are kept distinct. Geroscience describes molecular mechanisms such as genomic instability or cellular senescence. Ayurveda describes health through concepts such as agni, dhatu, srotas, constitution, strength, conduct and suitability of treatment. Laboratory findings may generate hypotheses about a herb, but they do not make an Ayurvedic category identical to a modern biomarker.

Modern Geroscience and the Hallmarks of Aging

The influential 2013 “Hallmarks of Aging” paper organized aging biology into nine interacting processes. A 2023 update expanded the framework to twelve hallmarks, reflecting developments in autophagy, inflammation and microbiome science:

1. Genomic instability
2. Telomere attrition
3. Epigenetic alterations
4. Loss of proteostasis
5. Disabled macroautophagy
6. Deregulated nutrient sensing
7. Mitochondrial dysfunction
8. Cellular senescence
9. Stem-cell exhaustion
10. Altered intercellular communication
11. Chronic inflammation
12. Dysbiosis

These hallmarks are a research framework, not a checklist that establishes whether a supplement extends life. Metformin, rapamycin and related mTOR inhibitors, NAD⁺ precursors, senolytics and other agents are being investigated in translational geroscience. Their effects on a pathway, laboratory marker or disease-related endpoint must be distinguished from demonstrated extension of healthy human lifespan.

Rasayana in the Charaka Samhita

Charaka Samhita, Chikitsa Sthana 1.1.7–8, describes Rasayana by its intended outcomes and as a means of obtaining excellent qualities of rasa and the subsequent dhatus. The passage associates Rasayana with longevity, memory, intellect, freedom from illness, youthful age, lustre, complexion, excellence of voice, strength of the body and senses, effective speech, respectability and brilliance. The correct expression is svaraudarya, excellence or fullness of voice; svarabheda denotes a disorder of the voice and is not listed as a Rasayana benefit.

• Dirgham ayuh: longevity
• Smriti and medha: memory and intellect
• Arogya: freedom from illness
• Tarunam vayah: youthful age
• Prabha, varna and svaraudarya: lustre, complexion and excellence of voice
• Dehendriya bala: strength of the body and senses

Classical Rasayana is broader than taking a single capsule. Charaka describes kutipraveshika, a highly regulated indoor method, and vatatapika, an outdoor method. The chapter also presents Achara Rasayana: conduct involving truthfulness, freedom from anger, nonviolence, calm speech, cleanliness, charity, compassion, self-restraint and balanced sleep and wakefulness. These elements place diet, behaviour, environment and supervision within the therapy itself.

Where the Two Frameworks Meet—and Where They Differ

Rasayana and geroscience overlap most clearly at the level of research questions: protection from cellular stress, preservation of function, cognition, metabolic regulation and resilience during aging. Their explanatory systems and standards of assessment remain different, so a correspondence should be treated as a possible bridge rather than a one-to-one translation.

Five Rasayana Examples With Corrected Classical and Scientific Context

The herbs and formulations below illustrate different parts of the Rasayana tradition. Their classical classifications, pharmacopoeial plant parts and modern findings should be stated separately so that traditional use is not confused with a demonstrated anti-aging drug effect.

Ashwagandha (Withania somnifera)

The Ayurvedic Pharmacopoeia identifies Ashwagandha as the dried mature root of Withania somnifera. It assigns tikta and kashaya rasa, laghu guna, ushna virya and madhura vipaka, with actions including Rasayana, Balya, Vajikarana and alleviation of Vata and Kapha. An in-vitro report found increased telomerase activity in HeLa cells exposed to Ashwagandha extract, but HeLa is a human cancer-cell line and the experiment does not establish safe telomerase activation in healthy people. A separate C. elegans study reported approximately 20% lifespan extension with a root extract in that worm model. Human studies are more relevant to stress and sleep outcomes than to longevity.

Amalaki (Phyllanthus emblica) and Amalaki Rasayana

The Pharmacopoeia describes Amalaki as possessing five tastes—madhura, amla, katu, tikta and kashaya, excluding salty taste—with laghu and ruksha guna, shita virya and madhura vipaka. It classifies the fruit as Rasayana and tridoshajit. Amalaki is central to several classical preparations, including Chyavanaprasha. In a small study of healthy adults aged 45–60 years, Amalaki Rasayana was administered for 45 days after a preparatory procedure; telomerase activity increased, while telomere length did not show a discernible change during the study period. The measured outcome supports further investigation of the formulation but does not establish telomere lengthening or lifespan extension.

Brahmi (Bacopa monnieri)

The Ayurvedic Pharmacopoeia identifies Brahmi as the dried whole plant of Bacopa monnieri. Its profile is madhura, tikta and kashaya rasa; laghu and sara guna; shita virya; and madhura vipaka. Its listed actions include Medhya, Rasayana, Ayushya and Matiprada. Systematic reviews of human trials have found the most consistent cognitive signal in memory free recall, generally after repeated use over several weeks. Preclinical findings concerning amyloid, neurogenesis or neuronal protection should not be presented as demonstrated clinical effects in Alzheimer’s disease.

Chyavanaprasha

Charaka’s Chyavanaprasha is an avaleha formulation centered on Amalaki and prepared with a large group of decoction drugs, ghee, sesame oil, sugar, honey and aromatic finishing ingredients. The classical formula is not accurately reduced to a universally fixed marketing claim such as “43 herbs,” because textual editions and commercial standards must be identified specifically. Charaka advises taking an amount that does not interfere with normal food intake and digestion. This makes digestive capacity and the complete formulation more relevant than a blanket instruction to take a fixed teaspoon on an empty stomach.

Shilajatu (Shilajit)

Charaka Samhita includes Shilajatu among Rasayana preparations. Modern descriptions often emphasize fulvic substances and mitochondrial theories, but claims that Shilajit directly acts as a clinically proven electron carrier or restores mitochondrial membrane potential in aging humans exceed available human findings. Raw or poorly characterized material can contain unwanted substances, including heavy metals or mycotoxins. Only purified, authenticated and contaminant-tested material should be considered, under professional guidance.

Classical Dose Ranges Are Not Universal Anti-Aging Prescriptions

Pharmacopoeial doses refer to specified crude drugs and plant parts, usually for adults, and serve as general professional guidance. They are not interchangeable with concentrated extracts, proprietary products or multi-ingredient formulations. Individual assessment remains necessary because preparation, digestive capacity, age, constitution, disease, medicines and accompanying substances can alter suitability.

What Rasayana Contributes to Healthy-Aging Practice

Rasayana contributes a structured view of rejuvenation in which medicine, diet, digestion, behaviour, environment and mental discipline are coordinated. Its distinct value lies in this therapeutic architecture rather than in forcing every classical term into a modern biochemical equivalent.

• Individualization: the substance and regimen are selected according to the person, digestive capacity, suitability and clinical context.
• Preparation and supervision: intensive methods such as kutipraveshika are regulated procedures, not home supplement routines.
• Behavioural discipline: Achara Rasayana makes sleep, restraint, truthful conduct, calm speech and compassion part of rejuvenative care.
• Formulation logic: classical compounds combine ingredients, processing methods and vehicles; they cannot be evaluated by naming one fashionable constituent alone.

What Modern Biology Contributes

Modern geroscience contributes precise definitions, laboratory assays, clinical endpoints, controlled comparisons and pharmacovigilance. It can determine whether an intervention changes a biomarker, improves a meaningful function, causes adverse effects or performs better than placebo or standard care. It also supplies analytical methods for confirming species, detecting adulteration and measuring microbial or heavy-metal contamination. These tools strengthen the safe study of traditional medicines without turning a biomarker change into a claim of human rejuvenation.

Safety and Clinical Boundaries

Rasayana substances are pharmacologically active and should not be treated as universally benign foods. Product identity, plant part, preparation, dose, duration, medical history and concurrent medicines all matter. Anti-aging language must never delay diagnosis or established treatment of fatigue, weight change, cognitive symptoms, sleep disturbance, endocrine disease or other health concerns.

A Responsible Starting Point

A sound first step is not a multi-herb “anti-aging stack.” Begin with a professional assessment, define the goal in practical terms—such as sleep, appetite, strength, recovery or memory—and choose one correctly identified preparation whose ingredients, plant parts, batch number and testing are disclosed. Review medicines and medical conditions before use, follow a time-limited plan, and monitor both benefits and adverse effects. For Chyavanaprasha or another compound Rasayana, use the practitioner’s product-specific guidance rather than assuming that every commercial version has the same composition or dose.

Research References

The following sources establish the classical passages, pharmacopoeial profiles, modern aging framework, preliminary clinical findings and safety boundaries used in this comparison:

• Telomeres, DNA Damage and Ageing: Potential Leads from Ayurvedic Rasayana (Anti-Ageing) Drugs
• The Hallmarks of Aging (2013)
• Hallmarks of Aging: An Expanding Universe (2023)
• Charaka Samhita, Rasayana Adhyaya
• The Ayurvedic Pharmacopoeia of India, Part I, Volume I
• The Ayurvedic Pharmacopoeia of India, Part I, Volume II
• Influence of Amalaki Rasayana on Telomerase Activity and Telomere Length
• NIH Office of Dietary Supplements: Ashwagandha
• The Cognitive-Enhancing Effects of Bacopa monnieri: A Systematic Review
• Shilajit: Composition and Purification-Related Safety

References

1. Telomeres, DNA Damage and Ageing: Potential Leads from Ayurvedic Rasayana (Anti-Ageing) Drugs (2020), PubMed
2. The hallmarks of aging (2013), PubMed
3. Hallmarks of aging: An expanding universe (2023), PubMed
4. Rewinding the Clock: Emerging Pharmacological Strategies for Human Anti-Aging Therapy (2025), PubMed Central
5. Charaka Samhita — Rasayana Adhyaya
6. Influence of Amalaki Rasayana on telomerase activity and telomere length in human blood mononuclear cells (2017), PubMed Central
7. Ayurvedic Pharmacopoeia of India
8. Scirp (scirp.org)
9. Withania somnifera root extract extends lifespan of Caenorhabditis elegans (2013), PubMed
10. Withania somnifera root extract extends lifespan of Caenorhabditis elegans (2013), PubMed Central
11. Ayurvedic Pharmacopoeia of India
12. The cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trials (2012), PubMed
13. Use of Bacopa monnieri in the Treatment of Dementia Due to Alzheimer Disease: Systematic Review of Randomized Controlled Trials (2022), PubMed Central
14. Shilajit: a natural phytocomplex with potential procognitive activity (2012), PubMed Central
15. NIH Office of Dietary Supplements
16. NCCIH